501(c)3 transforming how #LongCovid, #ME/CFS & Lyme+ are studied, diagnosed, and treated. Leading the #LongCovid Research Consortium.
PolyBio Research Foundation
Loading...
Written summaries of PolyBio’s Spring symposium presentations are available now! Check out shortened, simplified summaries, or full technical explanations of your favourite research projects.
2026-spring-symposium-polybio.netlify.app
#Longcovidresearch #mecfsresearch #chroniclymedisease
The support will also allow study coordinators to conduct home visits for certain participants to collect blood samples, helping expand access for individuals who are too ill or geographically constrained to consistently travel to study sites. 3/
Breaking: Funding from Vitalik Buterin’s Balvi Fund Expands Long COVID Low-Dose Rapamycin Clinical Trial with a New Open-Label Phase
1/
The open-label extension phase will allow all participants – including those initially randomized to placebo – to receive low-dose rapamycin during a defined follow-up period, an approach expected to improve willingness to enroll while preserving the rigor of the RCT phase. 2/
We are currently recruiting for this trial of low-dose Rapamycin for Long COVID. Those interested should:
-have a confirmed Long COVID diagnosis
-be 18 years or older
-be prepared to travel to the CoRE clinic for clinical visits (if possible)
Email [email protected] to apply now!
